Center for Device Innovation

Accelerating development of breakthrough medical devices
Center for Device Innovation
About Us

Accelerating Innovation

The Center for Device Innovation at Texas Medical Center (CDI @ TMC) was founded in 2017 with the mission to significantly impact healthcare by accelerating the development of breakthrough medical technologies.  As a collaboration between Johnson & Johnson Medical Devices Companies, Johnson & Johnson Innovation, and the Texas Medical Center, CDI @ TMC is a unique hybrid model for innovation that leverages the great resources of these larger enterprises, but with the speed and agility of an entrepreneurial start-up environment.  The focus is on early-stage concepts with high technical risk, rapidly developing and testing new devices to prove feasibility with faster timelines and capital efficiency.  Technologies that have been successfully de-risked can move into a commercialization pathway within Johnson & Johnson or spin out into a new company.



​Facilities & Resources

  • 25,000 sq. ft. maker space designed for device development
  • Full machine shop with advanced prototyping equipment
  • 60 work benches with private access configurations
  • Separate lab / office space for companies in residence
  • Dedicated labs for tissue testing, chemistry and electronics / mechanical testing
  • 12 private offices and 24 open workstations
  • VR system and visualization space
  • 2 conference rooms
  • Café space

Hybrid Approach

Text left


Development projects led by CDI team

Text right


Seed-stage start-ups supported by CDI

CDI @ TMC has a hybrid portfolio that includes both internal technology projects as well as start-up companies in residence.  The development team has flexibility to engage in new opportunities across a spectrum of different services and needs, including: independent development, collaborative co-development, machining / prototyping services, pre-clinical testing, manufacturing design, and strategic advising.  The current portfolio includes a broad range of initiatives across various clinical spaces and technology platforms aligned with J&J’s medical device areas of interest:

Text left

- cardiovascular (atrial fibrillation)

- neurovascular (stroke)

- oncology (lung cancer)

- orthopedics (osteoarthritis / osteoporosis)

Text right

- general and minimally invasive surgery

- robotics and digital surgery

- obesity / bariatrics

- vision care

Investment Criteria

CDI is always looking for new opportunities to fill development pipeline. The main criteria for evaluating any new IDEA:

IMPACT - significant value proposition for patients / healthcare and market opportunity

DIFFERENTIATION - potential advantages of technology and IP relative to competition

ENGAGEMENT - good utilization of the resources and development capabilities at CDI

ALIGNMENT - clear fit with J&J's areas of interest and longer-term strategy


CDI @ TMC has a dynamic team with a proven track record of success in the medical device industry, and a wide range of expertise and capabilities for front-end development.

Texas Medical Center

The Texas Medical Center is the largest medical complex in the world, with 60+ member institutions and over 106,000 employees on a 50 million sq. ft. campus.  Each year, the TMC has more 10 million total patient visits, 750,000 ER visits, and 180,000 surgical procedures performed.  With these expansive resources in such proximity, CDI @ TMC has access to a broad range of pre-clinical and clinical facilities for testing and feedback to accelerate development.  CDI @ TMC has established partnerships with several institutions to leverage these resources of the Houston ecosystem.


Johnson & Johnson to build new medical device facility in Houston

Johnson & Johnson (NYSE: JNJ) plans to build a first-of-its-kind medical device incubator in Houston, and it will be led by a prominent Bayou City cardiovascular surgeon.

Billy Cohn on the Past, Present and Future of the Total Artificial Hea...

It was standing-room only at Johnson & Johnson Innovation’s JLABS @ TMC as legendary cardiologist William “Billy” Cohn, M.D., vice president of medical devices at Johnson & Johnson, discussed the past, present and future of the total artificial heart.

Experts Say Houston Offers Medical Device Startups a Place to Thrive

The fireplace in the background may have been simulated, but the chat that took place this week at Johnson & Johnson Innovation’s JLABS @ TMC was definitely on fire.

A high-profile group of Texas Medical Center medical device experts that included William “Billy” Cohn, M.D., vice president of medical devices for Johnson & Johnson’s Center for Device Innovation; Arjun Desai, COO of JLABS and the Center for Device Innovation; William F. McKeon, president and CEO of the Texas Medical Center; and Nick Mourlas, senior director of new ventures for Johnson & Johnson Innovation, discussed topics from funding for medical devices to Houston’s innovation ecosystem, and even advice for President Donald Trump, in a fireside chat moderated by Lance Black., M.D., medical device innovation lead at the TMC Innovation Institute.

Contact Us

Make the Connection

For media inquiries, please contact:
Allie McCormick

For potential collaborations, please contact:
Joanna Nathan

Type of organization

Tour Information

Purpose / interest (check all that apply)
Requests need to be submitted at least 2 days in advance to accommodate scheduling.
Preferred date timing
Requests need to be submitted at least 2 days in advance to accommodate scheduling.
Alternate date timing